US Broker Ratings

TruBridge, Inc. (TBRG) Stock Analysis: Unveiling a 23.69% Potential Upside in Healthcare IT

For investors eyeing the healthcare information technology sector, TruBridge, Inc. (NASDAQ: TBRG) presents an intriguing opportunity. With a market capitalization of $300.38 million, TruBridge operates at the intersection of healthcare..

NANO-X IMAGING LTD (NNOX) Investor Outlook: Unpacking the 70% Potential Upside

Nano-X Imaging Ltd. (NASDAQ: NNOX), an innovative player in the healthcare sector, is gaining traction among investors keen on the medical devices industry. Based in Israel, the company is pioneering..

MiMedx Group, Inc. (MDXG) Stock Analysis: Exploring a 73.30% Potential Upside in the Healthcare Biotech Arena

MiMedx Group, Inc. (NASDAQ: MDXG) presents a compelling narrative for investors with its promising growth potential and innovative presence in the healthcare biotechnology sector. Headquartered in Marietta, Georgia, MiMedx specializes..

Harrow, Inc. (HROW) Stock Analysis: A 76% Upside Potential in the Eye of Investors

Harrow, Inc. (HROW) is making waves in the healthcare sector, particularly within the niche of specialty and generic drug manufacturing. With a market capitalization of $1.24 billion, this U.S.-based pharmaceutical..

agilon health, inc. (AGL) Stock Analysis: Can a Potential 144.91% Upside Revitalize Investor Confidence?

agilon health, inc. (NYSE: AGL), a healthcare services provider focused on senior care through primary care physicians, is navigating challenging waters in the medical care facilities industry. With a current..

MannKind Corporation (MNKD) Stock Analysis: Exploring a 170% Upside Potential

MannKind Corporation (MNKD), a U.S.-based biopharmaceutical company, is making waves in the healthcare sector with its focus on developing and commercializing therapeutic products for endocrine and orphan lung diseases. With..

NeoGenomics, Inc. (NEO) Stock Analysis: Navigating a 47.96% Potential Upside in the Diagnostics Sector

Investors with a keen interest in the healthcare sector’s diagnostics and research domain might find NeoGenomics, Inc. (NASDAQ: NEO) an intriguing prospect. With a market capitalization of $751.82 million, this..

89bio, Inc. (ETNB) Stock Analysis: Unpacking the 233% Potential Upside in Biotech

89bio, Inc. (NASDAQ: ETNB), a clinical-stage biopharmaceutical company, has been attracting significant attention from investors, particularly due to its substantial potential upside of 233.78%. Specializing in the development and commercialization..

Amphastar Pharmaceuticals (AMPH) Stock Analysis: Exploring a Potential 14% Upside Amid Market Dynamics

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a key player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, has been capturing investor attention with its recent market..

Neogen Corporation (NEOG) Stock Analysis: Exploring a 27.2% Potential Upside Amidst Market Challenges

Neogen Corporation (NASDAQ: NEOG), a key player in the healthcare sector specializing in diagnostics and research, presents a complex yet intriguing opportunity for investors. With a market capitalization of $1.11..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: Unveiling a Potential 106% Upside

For investors navigating the volatile waters of biotechnology, IDEAYA Biosciences, Inc. (NASDAQ: IDYA) emerges as a fascinating prospect. With a market capitalization of $2 billion, this precision medicine oncology company..

AdaptHealth Corp. (AHCO) Stock Analysis: Navigating a 40% Potential Upside in the Healthcare Sector

AdaptHealth Corp. (AHCO) stands as a notable player in the healthcare sector, specifically within the medical devices industry. Headquartered in Plymouth Meeting, Pennsylvania, AdaptHealth specializes in providing home medical equipment..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Impressive Revenue Growth and Strong Buy Ratings Signal Promising Potential

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH), a prominent player in the biotechnology sector, has been capturing investor attention with its recent stock performance and growth potential. Headquartered in Edmonton, Canada, Aurinia..

GRAIL, Inc. (GRAL) Stock Report: Analyzing the 23.89% Potential Upside in Healthcare Diagnostics

GRAIL, Inc. (NASDAQ: GRAL) stands at the forefront of innovation in the healthcare sector, carving a niche in the diagnostics and research industry. With a market capitalization of $1.18 billion,..

Pulse Biosciences, Inc. (PLSE) Stock Analysis: A Compelling 47.85% Potential Upside Awaits Investors

Pulse Biosciences, Inc. (NASDAQ: PLSE) represents an intriguing opportunity within the healthcare sector, particularly for investors keen on novel medical technologies. As a leader in bioelectric medicine, Pulse Biosciences has..

Opko Health, Inc. (OPK) Stock Analysis: Exploring a Potential 178% Upside with Strong Buy Ratings

Opko Health, Inc. (NASDAQ: OPK), a prominent player in the healthcare sector specializing in diagnostics and research, presents a compelling case for investors seeking growth opportunities amidst volatility. With a..

PACS Group, Inc. (PACS): Investor Outlook Reveals 168% Potential Upside in the Healthcare Sector

PACS Group, Inc. (NASDAQ: PACS) is emerging as a compelling opportunity for investors looking to capitalize on the healthcare sector, with a standout potential upside of 168.49%. This Farmington, Utah-based..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Exploring a 17.48% Potential Upside

Healthcare Services Group, Inc. (NASDAQ: HCSG), a stalwart in providing essential management and operational services within the healthcare industry, is currently drawing attention from investors with its notable growth potential...

Establishment Labs Holdings Inc (ESTA) Stock Analysis: Healthcare Innovator with a 64.82% Potential Upside

Investors eyeing the healthcare sector might find Establishment Labs Holdings Inc (NASDAQ: ESTA) an intriguing prospect. Operating within the medical devices industry, this Costa Rican company has carved a niche..

The Pennant Group, Inc. (PNTG) Stock Analysis: Healthcare Growth with a 29.25% Upside Potential

For investors seeking opportunities in the healthcare sector, The Pennant Group, Inc. (NASDAQ: PNTG) presents a compelling case. With a market capitalization of $903.8 million, this company operates in the..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds